Not provided
Not provided
Not provided
Not provided
The study has stopped after the investigator's decision. The latter desires to analyse the collected data at 60 patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital, Rouen | OTHER |
| University Hospital, Caen | OTHER |
Not provided
Not provided
Not provided
Not provided
Physical exercises program is known to improve quality of life, chronical fatigue and appears to be a behavioural recommendation against cancer as primary and tertiary prevention. Nutritional status is also important in cancer patients: a loss of 5% of weight increases the complication risks and decreases survival and the quality of life. Interactions between physical activity and haematological malignancies are less described compared to solid cancers. Methodology and protocols are also heterogeneous. Supervised exercises program improves the physical condition and the quality of life; however there are few randomised studies versus a controlled group. Post autograft evaluation for myeloma patients showed a physical deficit with increased fat mass, but in this particular population physical exercises need to be more explored. This project is a randomised study versus controlled group that evaluates supervised physical exercises program in a homogenous population: patients under-65-years-old with multiple myeloma and who will undergo autologous stem cell transplantation.
Physical exercises program is known to improve quality of life, chronical fatigue and appears to be a behavioural recommendation against cancer as primary and tertiary prevention. Nutritional status is also important in cancer patients: a loss of 5% of weight increases the complication risks and decreases survival and the quality of life. Interactions between physical activity and haematological malignancies are less described compared to solid cancers. This multicentre project is a randomised study versus controlled group that evaluates supervised physical exercises program in a homogenous population: patients under-65-years-old with multiple myeloma and who will undergo autologous stem cell transplantation. The hypothesis of this study is that a supervised physical exercises program during and after autograft might have a positive impact on the physical capacities and the quality of life.
In the experimental arm, patients will benefit regularly from a physical exercises program during their hospitalization. When going back home, they will be given a practical help kit with specific equipment (dumbbell, elastic), an actimeter with heart rate monitoring (in order to have an objective collection of the physical practice in addition to a self-evaluation) and a physical exercises program on paper and video supports, that patients would have learnt during their hospitalization. Furthermore, SMS will be regularly sent to remind them to practice. In the controlled arm, patients will be hospitalized in the same conditions than the experimental group and can practice if they want. At the end of the hospitalization, they will receive a paper document with global informations about physical exercises including a few simple exercises. Evaluations will be carried out in both arms at day 0, day 30 and day 90 from autograft. The post graft follow up will be done at the same time as the medical consultation and before the maintenance treatment.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Physical exercise arm | Experimental | patients will benefit regularly from a physical exercises program during their hospitalization. When going back home, they will be given a practical help kit with specific equipment (dumbbell, elastic), an actimeter with heart rate monitoring (in order to have an objective collection of the physical practice in addition to a self-evaluation) and a physical exercises program on paper and video supports, that patients would have learnt during their hospitalization. Furthermore, SMS will be regularly sent to remind them to practice |
|
| controlled arm | Active Comparator | patients will be hospitalized in the same conditions than the experimental group and will be able to practice if they want. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Physical exercises | Behavioral | patients will benefit regularly from a physical exercises program during their hospitalization. When going back home, they will be given a practical help kit with specific equipment (dumbbell, elastic), an actimeter with heart rate monitoring (in order to have an objective collection of the physical practice in addition to a self-evaluation) and a physical exercises program on paper and video supports, that patients would have learnt during their hospitalization. |
| Measure | Description | Time Frame |
|---|---|---|
| Measure of quality of life with EORTC QLQ-C30 questionnaire | The quality of life will be measure with the EORTC quality QLQ-C30 questionnaire to assess the quality of life of cancer patients. Scales range in score is from 0 to 100. A high score for a functional scale represents a high/healthy level of functioning whereas a high score for a symptom scale or item represents a high level of symptomatology or problems. | at day 0 from autograft as patient will be hospitalized. |
| Measure of quality of life with EORTC QLQ-C30 questionnaire | The quality of life will be measure with the EORTC quality QLQ-C30 questionnaire to assess the quality of life of cancer patients. Scales range in score is from 0 to 100. A high score for a functional scale represents a high/healthy level of functioning whereas a high score for a symptom scale or item represents a high level of symptomatology or problems. | at day 30 from autograft as patient will be hospitalized. |
| Measure of quality of life with EORTC QLQ-C30 questionnaire | The quality of life will be measure with the EORTC quality QLQ-C30 questionnaire to assess the quality of life of cancer patients. Scales range in score is from 0 to 100. A high score for a functional scale represents a high/healthy level of functioning whereas a high score for a symptom scale or item represents a high level of symptomatology or problems. | at day 90 from autograft as patient will be hospitalized. |
| Measure of quality of life with QLQ-MY20 questionnaire | The quality of life will be measure with the QLQ-MY20 questionnaire to assess the quality of life of cancer patients. QLQ-MY20 domain scores are averaged and transformed linearly to a score ranging from 0-100. A high score for Disease Symptoms and Side Effects of Treatment represents a high level of symptomatology or problems, whereas a high score for Future Perspective and Body Image represents better outcomes. | at day 0 from autograft as patient will be hospitalized. |
| Measure | Description | Time Frame |
|---|---|---|
| Measure of fatigue evaluated by Piper scale | The Piper Fatigue Scale is composed of 22 numerically scaled, "0" to "10" items that measure four dimensions of subjective fatigue. This will give an average score that remains on the same "0" to "10"numeric scale. O is the moderate score and 10 is the worst score. | at day 0 from autograft as patient will be hospitalized. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| caroline delette, MD | CHU Amiens | Principal Investigator |
| Pierre Morel, MD | CHU Amiens | Principal Investigator |
| Fabrice Jardin, Pr | CHU Rouen | Principal Investigator |
| Oana Brehar, MD | CHU Rouen | Principal Investigator |
| Vincent Camus, MD | CHU Rouen | Principal Investigator |
| Nathalie Cardinael, MD | CHU Rouen | Principal Investigator |
| Nathalie Contentin, MD | CHU Rouen | Principal Investigator |
| Marie-Laure Fontoura, MD | CHU Rouen | Principal Investigator |
| Carole Fronville Varnier, MD | CHU Rouen | Principal Investigator |
| Hélène Lanic, MD | CHU Rouen |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Amiens | Amiens | 80054 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009101 | Multiple Myeloma |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D054219 | Neoplasms, Plasma Cell |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Optional physical exercises | Behavioral | patients will be proposed for the physical exercises and will practice them if they want. |
|
| Measure of quality of life measured with QLQ-MY20 questionnaire | The quality of life will be measure with the QLQ-MY20 questionnaire to assess the quality of life of cancer patients. QLQ-MY20 domain scores are averaged and transformed linearly to a score ranging from 0-100. A high score for Disease Symptoms and Side Effects of Treatment represents a high level of symptomatology or problems, whereas a high score for Future Perspective and Body Image represents better outcomes. | at day 30 from autograft as patient will be hospitalized. |
| Measure of quality of life measured with QLQ-MY20 questionnaire | The quality of life will be measure with the QLQ-MY20 questionnaire to assess the quality of life of cancer patients. QLQ-MY20 domain scores are averaged and transformed linearly to a score ranging from 0-100. A high score for Disease Symptoms and Side Effects of Treatment represents a high level of symptomatology or problems, whereas a high score for Future Perspective and Body Image represents better outcomes. | at day 90 from autograft as patient will be hospitalized. |
| Measure of fatigue evaluated by Piper scale | The Piper Fatigue Scale is composed of 22 numerically scaled, "0" to "10" items that measure four dimensions of subjective fatigue. This will give an average score that remains on the same "0" to "10"numeric scale. O is the moderate score and 10 is the worst score. | at day 30 from autograft as patient will be hospitalized. |
| Measure of fatigue evaluated by Piper scale | The Piper Fatigue Scale is composed of 22 numerically scaled, "0" to "10" items that measure four dimensions of subjective fatigue. This will give an average score that remains on the same "0" to "10"numeric scale. O is the moderate score and 10 is the worst score. | at day 90 from autograft as patient will be hospitalized. |
| Emilie Lemasle Hue, MD | CHU Rouen | Principal Investigator |
| Pascal Lenain, MD | CHU Rouen | Principal Investigator |
| Stéphane Lepretre, MD | CHU Rouen | Principal Investigator |
| Anna-Lise Menard, MD | CHU Rouen | Principal Investigator |
| Aspasia Stamatoullas-Bastard, MD | CHU Rouen | Principal Investigator |
| Hervé Tilly, MD | CHU Rouen | Principal Investigator |
| Gandhi L Damaj, Pr | University Hospital, Caen | Principal Investigator |
| Stéphane Cheze, MD | University Hospital, Caen | Principal Investigator |
| Margaret Macro, MD | University Hospital, Caen | Principal Investigator |
| D020141 |
| Hemostatic Disorders |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010265 | Paraproteinemias |
| D001796 | Blood Protein Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D006474 | Hemorrhagic Disorders |
| D008232 | Lymphoproliferative Disorders |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |